289 related articles for article (PubMed ID: 12505350)
21. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
22. Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicity.
Yang CS; Brady JF; Hong JY
FASEB J; 1992 Jan; 6(2):737-44. PubMed ID: 1537464
[TBL] [Abstract][Full Text] [Related]
23. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
Lee IS; Kim D
Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
[TBL] [Abstract][Full Text] [Related]
24. Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms.
Ingelman-Sundberg M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):89-104. PubMed ID: 14574440
[TBL] [Abstract][Full Text] [Related]
25. Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.
Guengerich FP
Chem Res Toxicol; 2017 Jan; 30(1):2-12. PubMed ID: 27472660
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450 enzymes and genotype-guided drug therapy.
Roederer MW
Curr Opin Mol Ther; 2009 Dec; 11(6):632-40. PubMed ID: 20072940
[TBL] [Abstract][Full Text] [Related]
27. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
28. 57 varieties: the human cytochromes P450.
Lewis DF
Pharmacogenomics; 2004 Apr; 5(3):305-18. PubMed ID: 15102545
[TBL] [Abstract][Full Text] [Related]
29. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
[TBL] [Abstract][Full Text] [Related]
30. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
Tomaszewski P; Kubiak-Tomaszewska G; Pachecka J
Acta Pol Pharm; 2008; 65(3):307-18. PubMed ID: 18646550
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
Oscarson M
Clin Chem Lab Med; 2003 Apr; 41(4):573-80. PubMed ID: 12747605
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry.
Zanger UM; Raimundo S; Eichelbaum M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jan; 369(1):23-37. PubMed ID: 14618296
[TBL] [Abstract][Full Text] [Related]
33. Novel advances in cytochrome P450 research.
Singh D; Kashyap A; Pandey RV; Saini KS
Drug Discov Today; 2011 Sep; 16(17-18):793-9. PubMed ID: 21864709
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphism of cytochrome P450. Functional consequences and possible relationship to disease and alcohol toxicity.
Ingelman-Sundberg M; Johansson I; Persson I; Oscarson M; Hu Y; Bertilsson L; Dahl ML; Sjöqvist F
EXS; 1994; 71():197-207. PubMed ID: 8032151
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetics of cytochrome P450 (CYP) in the elderly.
Seripa D; Pilotto A; Panza F; Matera MG; Pilotto A
Ageing Res Rev; 2010 Oct; 9(4):457-74. PubMed ID: 20601196
[TBL] [Abstract][Full Text] [Related]
36. The Gerhard Zbinden Memorial Lecture. Genetic polymorphism of drug metabolizing enzymes. Implications for toxicity of drugs and other xenobiotics.
Ingelman-Sundberg M
Arch Toxicol Suppl; 1997; 19():3-13. PubMed ID: 9079190
[No Abstract] [Full Text] [Related]
37. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
38. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
39. Role of gene knockout and transgenic mice in the study of xenobiotic metabolism.
Gonzalez FJ
Drug Metab Rev; 2003 Nov; 35(4):319-35. PubMed ID: 14705864
[TBL] [Abstract][Full Text] [Related]
40. Probing the world of cytochrome P450 enzymes.
Frye RF
Mol Interv; 2004 Jun; 4(3):157-62. PubMed ID: 15210869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
